AI-Based Diagnostics For Hospitals

The confluence of large clinical databases and high-performance artificial intelligence (AI) models is enabling a new paradigm in medical diagnostics. Biocogniv has built proprietary platforms and datasets that power real world evidence of unprecedented scale, allowing them to discover new opportunities without incurring the risk and high cost of traditional clinical trials. Their first product, Sepsis aiMarker™, can detect and predict sepsis up to 72 hours in advance using only routine laboratory panels collected in the emergency room, and has been awarded a Breakthrough Designation by FDA.